Quantcast

PENNSYLVANIA RECORD

Thursday, May 2, 2024

Case activity for Kristy Lynn Howe vs Teva Branded Pharmaceutical Products R&D Inc. on Feb. 15

Filings
Shutterstock 146730020

shutterstock.com

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Kristy Lynn Howe against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC. D B a Teva Women's Health, INC., THE Cooper Companies Inc., Teva Branded Pharmaceutical Products R&D Inc., Teva Pharmaceutcials USA Inc., Teva Women's Health Inc., Individually, and and Teva Women's Health LLC, Individually and on Feb. 15.

'Notice Of Removal By Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc., Teva Branded Pharmaceutical Products R&d, Inc., Teva Pharmaceutcials Usa, Inc., Coopersurgical, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/a Teva Women's Health, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., The Cooper Companies, Inc (filing Fee $ 402 Receipt Number 0313-14915229), Filed By Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc., Teva Branded Pharmaceutical Products R&d, Inc., Teva Pharmaceutcials Usa, Inc., Coopersurgical, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/A Teva Women's Health, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., The Cooper Companies, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By The Cooper Companies, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Pharmaceutcials Usa, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Branded Pharmaceutical Products R&d, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Inc. By Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Llc F/k/A Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health Llc F/k/A Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:21-cv-00689 was filed in the U.S. District Court for the Eastern District of Pennsylvania on Feb. 15.

More News